National Pension Service Buys 22,372 Shares of Intuitive Surgical, Inc. $ISRG

National Pension Service increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 749,814 shares of the medical equipment provider’s stock after purchasing an additional 22,372 shares during the quarter. National Pension Service’s holdings in Intuitive Surgical were worth $298,186,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in ISRG. Main Street Group LTD bought a new position in Intuitive Surgical in the first quarter worth about $30,000. Compass Financial Management LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $30,000. Vermillion Wealth Management Inc. boosted its holdings in shares of Intuitive Surgical by 58.1% in the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after buying an additional 25 shares in the last quarter. Motiv8 Investments LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $34,000. Finally, Evergreen Advisors LLC purchased a new position in shares of Intuitive Surgical in the 1st quarter worth approximately $35,000. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, Director Gary Guthart sold 10,000 shares of the company’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total value of $4,000,000.00. Following the transaction, the director directly owned 1,245,679 shares of the company’s stock, valued at $498,271,600. This represents a 0.80% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the firm’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $375.57, for a total value of $28,918.89. Following the completion of the transaction, the executive vice president owned 881 shares of the company’s stock, valued at $330,877.17. This trade represents a 8.04% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 11,281 shares of company stock valued at $4,485,432 over the last three months. 0.60% of the stock is owned by corporate insiders.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: A large meta-analysis found that da Vinci robotic-assisted surgery was associated with statistically significant improvements across 13 common benign conditions, including shorter hospital stays and faster returns to work versus laparoscopic and open surgery. The findings support the clinical value of Intuitive’s platform and could help drive hospital adoption. New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery
• Positive Sentiment: BTIG reaffirmed its “buy” rating and assigned a $469 price target, implying substantial upside from recent trading levels. Other analyst commentary also remains broadly favorable, although investors may be discounting some recommendations because sell-side ratings tend to be optimistic. BTIG reaffirms buy rating on Intuitive Surgical
• Positive Sentiment: Articles note that ISRG is trading at its cheapest valuation in roughly a decade. Combined with recent revenue growth of about 18% and strong earnings execution, the lower valuation is attracting interest from value-oriented investors. ISRG stock trading at its cheapest in 10 years
• Neutral Sentiment: Intuitive presented at the Wells Fargo Healthcare Conference, keeping investor attention on procedure trends, guidance, competition, and the company’s long-term robotic-surgery opportunity. Intuitive Surgical Wells Fargo Healthcare Conference transcript
• Negative Sentiment: Recent selling pressure has been linked to slower U.S. procedure growth, rising costs, competitive threats, and potential effects from GLP-1 drugs. Investors are also questioning whether the company’s earnings multiple is justified while growth moderates. Why Intuitive Surgical fell more than the broader market
• Negative Sentiment: EVP Mark Brosius reported two sales totaling 69 shares. The transactions were made under a pre-arranged Rule 10b5-1 plan and are small relative to his remaining holdings, limiting their significance; however, broader insider activity has consisted predominantly of sales rather than purchases.

Intuitive Surgical Stock Up 0.9%

Shares of Intuitive Surgical stock opened at $353.24 on Thursday. The firm has a market capitalization of $124.79 billion, a P/E ratio of 40.46, a PEG ratio of 2.64 and a beta of 1.47. The company has a 50 day moving average price of $378.72 and a 200 day moving average price of $425.22. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter in the previous year, the firm earned $1.81 EPS. Intuitive Surgical’s revenue was up 18.4% compared to the same quarter last year. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently commented on ISRG shares. Raymond James Financial reissued an “outperform” rating and set a $483.00 target price (down from $577.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Mizuho set a $500.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a research report on Wednesday, July 15th. The Goldman Sachs Group set a $558.00 price objective on Intuitive Surgical in a report on Wednesday, May 27th. Finally, BMO Capital Markets reiterated an “outperform” rating on shares of Intuitive Surgical in a report on Monday, July 20th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $508.68.

About Intuitive Surgical

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company’s principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.